Paul Medeiros

CEO & Board Member
Chief Executive Officer, Q-State Biosciences
As Chief Executive Officer of Q-State Biosciences, Paul Medeiros is responsible for overseeing the company’s growth and sharpening its vision. He has nearly 25 years of global executive pharmaceutical experience with an extensive track record of success in biopharma strategy, operations, R&D portfolio and corporate development. Prior to Q-State, Paul served as President and founding executive of Imbrium Therapeutics and directed the company’s business operations and R&D portfolio in the areas of pain and CNS therapeutics. He concurrently served as President of the associated investment / accelerator firm Greenfield BioVentures. In addition to these roles, Paul has fulfilled multiple corporate leadership positions within other biopharmaceutical companies including Mundipharma International in Cambridge UK, AVI BioPharma (now Sarepta Therapeutics), and Schering-Plough Pharmaceuticals. He began his pharma career as an MBA leadership trainee at Merck & Company. Paul has also served on the boards of directors of Praxis Precision Medicines, Kolltan Pharmaceuticals and EDO Pharmaceuticals GMBH. He received his AB with Honors from Brown University and his MBA from Columbia Business School

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lectus vulputate ornare mattis varius sit pulvinar pharetra elit platea. Felis sit arcu tellus hendrerit id tristique tristique cursus. Tempor leo aliquet semper aliquet quis. At ullamcorper elit sed nisl lorem ultricies convallis sapien.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lectus vulputate ornare mattis varius sit pulvinar pharetra elit platea. Felis sit arcu tellus hendrerit id tristique tristique cursus.